INJECTION SITE ATROPHY

This adverse event was reported 1646 times

INJECTION SITE ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 4 0.0221
1 ASFOTASE ALFA 166 0.0161
2 TECHNETIUM TC 99M OXIDRONATE 1 0.0074
3 GLATIRAMER ACETATE 325 0.0055
4 TRIAMCINOLONE ACETONIDE 165 0.0052
5 OCTOCRYLENE, AVOBENZONE 2 0.0045
6 SOMATROGON-GHLA 5 0.0040
7 INTERFERON BETA-1B 66 0.0035
8 LUMASIRAN 1 0.0026
9 GLATIRAMER ACETATE INJECTION 12 0.0025
See all drugs enriched for association with INJECTION SITE ATROPHY